Back
AbbVie Quote, Financials, Valuation and Earnings
Sponsored
ABBV
Sponsored
The Trump Nuclear MEGA-Boom!
Here's why nuclear stocks are expected to skyrocket under Trump's second term.
Sell
40
ABBV
AbbVie
Last Price:
$175.68
Seasonality Move:
1.78%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.AbbVie Price Quote
$175.68
+0.10 (+2.43%)
(Updated: December 21, 2024 at 5:13 AM ET)
AbbVie Key Stats
Sell
40
AbbVie (ABBV)
is a Sell
Day range:
$170.66 - $176.80
52-week range:
$153.09 - $207.32
Dividend yield:
3.53%
P/E ratio:
64.55
P/S ratio:
5.61
P/B ratio:
51.44%
Volume:
17.5M
Avg. volume:
7.6M
1-year change:
15.75%
Market cap:
$310.3B
Revenue:
$54.3B
EPS:
$2.88
How Much Does AbbVie Make?
Data Unavailable
Is AbbVie Growing As A Company?
Data Unavailable
AbbVie Stock Price Performance
What Is AbbVie 52-Week High & Low?
AbbVie Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy AbbVie?
Data Unavailable
Is AbbVie Cash Flow Positive?
Data Unavailable
AbbVie Return On Invested Capital
Data Unavailable
AbbVie Earnings Date & Stock Price
-
What Is AbbVie's Stock Price Today?A single share of ABBV can be purchased today for 175.58
-
What Is AbbVie’s Stock Symbol?
-
When Is AbbVie’s Next Earnings Date?The next quarterly earnings date for AbbVie is scheduled on January 31, 2025
-
When Is ABBV's next ex-dividend date?AbbVie's next ex-dividend date is January 15, 2025
-
How To Buy AbbVie Stock?You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AbbVie Competitors
AbbVie Dividend Yield
Data Unavailable
AbbVie Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -12% | 2.82% |
Revenue: | 3.83% | 1.28% |
Analyst Recommendations
Buy Recommendations: | 13 |
---|---|
Hold Recommendations: | 10 |
Sell Recommendations: | 0 |
Price Target: | 202.54 |
Upside from Last Price: | 15.36% |
Major Shareholders
Data Unavailable